Comparison of Recipient Outcomes After Kidney Transplantation: In-House Versus Imported Deceased Donors

S. Y. Lim, J. G. Gwon, M. G. Kim, C. W. Jung

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Background: Increased cold ischemia time in cadaveric kidney transplants has been associated with a high rate of delayed graft function (DGF), and even with graft survival. Kidney transplantation using in-house donors reduces cold preservation time. The purpose of this study was to compare the clinical outcomes after transplantation in house and externally. Methods: We retrospectively reviewed the medical records of donors and recipients of 135 deceased-donor kidney transplantations performed in our center from March 2009 to March 2016. Results: Among the 135 deceased donors, 88 (65.2%) received the kidneys from in-house donors. Median cold ischemia time of transplantation from in-house donors was shorter than for imported donors (180.00 vs 300.00 min; P <.001). The risks of DGF and slow graft function were increased among the imported versus in-house donors. Imported kidney was independently associated with greater odds of DGF in multivariate regression analysis (odds ratio, 4.165; P =.038). However, the renal function of recipients at 1, 3, 5, and 7 years after transplantation was not significantly different between the 2 groups. Conclusions: Transplantation with in-house donor kidneys was significantly associated with a decreased incidence of DGF, but long-term graft function and survival were similar compared with imported donor kidneys.

    Original languageEnglish
    Pages (from-to)1025-1028
    Number of pages4
    JournalTransplantation Proceedings
    Volume50
    Issue number4
    DOIs
    Publication statusPublished - 2018 May

    Bibliographical note

    Publisher Copyright:
    © 2018 Elsevier Inc.

    ASJC Scopus subject areas

    • Surgery
    • Transplantation

    Fingerprint

    Dive into the research topics of 'Comparison of Recipient Outcomes After Kidney Transplantation: In-House Versus Imported Deceased Donors'. Together they form a unique fingerprint.

    Cite this